TopNewsOn
Health

STAT+: FDA discloses reasons for rejecting Summit drug

Elaine Chen and Adam Feuerstein·STAT News·November 18, 2026

The FDA published its complete response letter to Summit Therapeutics explaining why it rejected the biotech's closely watched lung cancer drug:

Read the full story at STAT News →